Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Current Assets (2020 - 2025)

Celularity (CELU) has disclosed Current Assets for 6 consecutive years, with $10.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets fell 26.93% to $10.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.6 million, a 26.93% decrease, with the full-year FY2024 number at $20.6 million, up 3.88% from a year prior.
  • Current Assets was $10.6 million for Q3 2025 at Celularity, down from $17.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $91.3 million in Q3 2021 to a low of $57811.0 in Q2 2021.
  • A 5-year average of $31.7 million and a median of $20.6 million in 2024 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: plummeted 92.91% in 2021, then soared 130416.68% in 2022.
  • Celularity's Current Assets stood at $59.1 million in 2021, then crashed by 43.31% to $33.5 million in 2022, then tumbled by 40.92% to $19.8 million in 2023, then rose by 3.88% to $20.6 million in 2024, then crashed by 48.47% to $10.6 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Current Assets are $10.6 million (Q3 2025), $17.3 million (Q2 2025), and $22.1 million (Q1 2025).